Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMPRYTW)

Drug Name

DCB-3503 Drug Info

Synonyms

DCB-3503; UNII-TXF835U41K; NSC-716802; CHEMBL399454; TXF835U41K; NSC716802; AC1L8JU6; (13aS,14S)-Tylophorinine; 87302-58-7; SCHEMBL12389871; CTK7A0055; BDBM50213933; Dibenzo(f,H)pyrrolo(1,2-b)isoquinolin-14-ol, 9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (13aS,14S)-; NCI60_040362; Dibenzo(f,H)pyrrolo(1,2-b)isoquinolin-14-ol, 9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (13as-trans)-; (13aS,14S)-2,3,6,7-tetramethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizin-14-ol; Dibenzo[f,2-b]isoquinolin-14-ol, 9

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 402628
CAS Number: CAS 87302-58-7
TTD Drug ID: DMPRYTW

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting c-Jun messenger RNA (c-Jun mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Pergularinine	DM8OC9F	Discovery agent	N.A.	Investigative	[1]
[(R)-(+)-deoxytylophorinidine	DMPFUBE	Discovery agent	N.A.	Investigative	[1]
ISIS 10582	DMB5F9H	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
c-Jun messenger RNA (c-Jun mRNA)	TTS7IR5	JUN_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4338-42.
2	US patent application no. 6,312,900, Antisense oligonucleotide compositions and methods for the modulation of activating protein 1.